Inaugural Forum on Pre-Approval Expanded Access Programmes for the Bio/Pharmaceutical Industry

17-18 November 2009, London, United Kingdom. In October of 2008, CBI's Premier Forum on Pre-Approval Access Programs provided the first networking platform for international executives to discuss regulations, values and best practices for providing pre-approved drugs to patients in critical need. A year later, CBI has created a U.K.-based forum in addition to the U.S. event to help facilitate a global discussion. Don't miss your opportunity to network with likeminded professionals and:

Explore barriers to access in specific therapeutic areas including: oncology, infectious disease, orphan and rare diseases
Identify best practices for selecting and implementing specific treatment programmes for individual patients
Analyze the market uptake from previous launches that initiated an NPP prior to approval
Understand how to coordinate named patient programmes through the regulatory agencies at the macro and micro level

You will benefit from attending this event if you are an executive or senior-level director from the pharmaceutical, biotech or medical devices company with responsibilities or involvement in the following areas:

Medical Affairs
Clinical Affairs/Operations
Market Access
Import/Export
Program Management
Global Business Development
Regulatory
Legal
Patient Services
Commercial Development
Global Communication
Marketing
Ethics
Research and Development

This conference would also be of interest to consulting companies, communication firms, researchers and technology providers who work with the above groups to solicit for or are the benefits of grants from the biotech and pharmaceutical companies.

For furhter information and registration, please visit:
http://www.cbinet.com/show_conference.cfm?confCode=PC09075

PharmaNews.eu